Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Heptares Therapeutics Ltd.

Division of Sosei Group Corp.

Latest From Blue Earth Diagnostics Ltd.

Blue Earth Extends Global PET Reach With EU Approval

Blue Earth Diagnostics, a molecular imaging agent specialist spun out of GE Healthcare, has secured EU approval to market its PET tracer for detecting recurrent prostate cancer. Axumin, which was approved in the US a year ago, is said to be only PET imaging agent for this indication in the EU.

Diagnostic Imaging Cancer

CHMP’s March Recommendations Include Dinutuximab, Nonacog Beta Pegol And Trumenba

The European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) meets monthly to review applications for centralized EU marketing authorization. Here’s a summary of their March 2017 recommendations.

Approvals Europe

No Dominant Sponsors In US FDA's 2016 Novel Approvals Class

No company received more than two approvals among the 28 novel agents approved in 2016 by US FDA's drug and biologics centers combined.

Approvals BioPharmaceutical

Blue Earth Wins FDA Approval For Prostate Cancer PET Tracer

GE spin-out Blue Earth Diagnostics is betting that positron emission tomography imaging to aid recurrent prostate cancer treatment is an untapped market with the FDA approval of its Axumin molecular imaging agent.

Medical Device
See All

Company Information

  • Industry
  • Pharmaceuticals
  • Therapeutic Areas
  • Metabolic Disorders
  • Neurology, Nervous System
  • Alias(es)
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • Europe
      • Western Europe
        • UK
  • Parent & Subsidiaries
  • Sosei Group Corp.
  • Senior Management
  • Malcolm Weir, PhD, Chmn. & CEO
    Fiona Marshall , PhD, CSO
    Barry Kenny, PhD, Chief Business Officer
    Tim Tasker, MD, VP, Dev. & CMO
    Ali Jazayeri, CTO
  • Contact Info
  • Heptares Therapeutics Ltd.
    Phone: (44) 1707 358 628
    Broadwater Rd.
    Welwyn Garden City, AL7 3AX